Rare and Orphan Lung Diseases, An Issue of Clinics in Chest Medicine

In this issue of Clinics in Chest Medicine, guest editors Drs. Cormac McCarthy and Nishant Gupta bring their considerable expertise to the topic of Rare and Orphan Lung Diseases. Top experts discuss both rare and orphan diseases (those which are not widely researched, those where specific treatments are not available, and those which may only be of limited interest to scientists and doctors). Topics in this issue include primary ciliary dyskinesia, multiple cystic lung diseases, and idiopathic eosinophilic pneumonias.Contains 17 relevant, practice-oriented topics including lymphangioleiomyomatosis; pulmonary Langerhans cell histiocytosis; Birt Hogg Dube syndrome; lymphatic disorders and the lung; plmonary vasculitis; antisynthetase syndromes; monogenic familial ILD; Hermansky Pudlak syndrome; and moreProvides in-depth clinical reviews on rare and orphan lung diseases, offering actionable insights for clinical practicePresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews

Prior to being appointed in 2018 as Associate Professor of Medicine in UCD and Consultant Respiratory Physician at St. Vincent's Hospital Group Associate Professor of Medicine in UCD, Cormac McCarthy was the Rare Lung Disease Scholar at the Rare Lung Disease Consortium in the United States, based in Cincinnati, Ohio. He is a graduate of the Royal College of Surgeons in Ireland (RCSI), obtaining an Honours degree in Medicine in 2007. He completed higher specialist training through the Royal College of Physician of Ireland (RCPI) and was awarded a Certificate of Satisfactory Completion of Specialist Training by the Irish Committee on Higher Specialist Training (Respiratory and General Internal Medicine) in 2017. He continued post-graduate training at the University of Cincinnati Medical Center and Cincinnati Children's Hospital, where he completed an ACGME-accredited Clinical Fellowship in Genetic Pulmonary Disease, and he continued his training there as a Rare Lung Disease Scholar where he conducted research, resulting in many high impact publications. His primary research areas were on the molecular mechanisms of lung disease, utilizing pathogenesis approach to develop new therapies. He continues to have a strong interest in all lung diseases, with a particular focus on interstitial lung disease, rare lung disease, cystic lung disease syndromes and obstructive airway disorders.